Relationships between urinary antimony levels and both mortalities and prevalence of cancers and heart diseases in general US population, NHANES 1999–2010

Science of the Total Environment

Volumn 571, Issue , 2016, Pages 452-460

  Guo, Jing ^a   Su, Liling ^a   Zhao, Xinyuan ^a   Xu, Zhengping ^a   Chen, Guangdi ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antimony; Cancer; Heart disease; Mortality; NHANES

Indexed keywords

ANTIMONY; CARDIOLOGY; HAZARDS; HEALTH; HEALTH HAZARDS; HEART; OCCUPATIONAL DISEASES; PATHOLOGY; POPULATION STATISTICS; REGRESSION ANALYSIS; SURVEYS;

CANCER; CARDIO-VASCULAR DISEASE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURES; HEART DISEASE; LOGISTIC REGRESSION MODELS; MORTALITY; NHANES;

DISEASES;

ANTIMONY;

ANTIMONY; CANCER; CARDIOVASCULAR DISEASE; DISEASE PREVALENCE; HEALTH IMPACT; HEALTH RISK; MORTALITY; OCCUPATIONAL EXPOSURE; URINE;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; UNITED STATES; URINE LEVEL; AGED; CHEMICALLY INDUCED; MIDDLE AGED; NEOPLASM; NUTRITION; RISK FACTOR; URINE; VERY ELDERLY; YOUNG ADULT;

UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTIMONY; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NUTRITION SURVEYS; PREVALENCE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84989867369     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2016.07.011     Document Type: Article

References (61)

1. Agarwal, S., Zaman, T., Tuzcu, E.M., Kapadia, S.R., Heavy metals and cardiovascular disease: results from the National Health and Nutrition Examination Survey (NHANES) 1999–2006. Angiology 62 (2011), 422–429.
2. Alvarez, M., Malecot, C.O., Gannier, F., Lignon, J.M., Antimony-induced cardiomyopathy in guinea-pig and protection by L-carnitine. Br. J. Pharmacol. 144 (2005), 17–27.
3. Alvarez-Ayuso, E., Otones, V., Murciego, A., Garcia-Sanchez, A., Regina, I.S., Antimony, arsenic and lead distribution in soils and plants of an agricultural area impacted by former mining activities. Sci. Total Environ. 439 (2012), 35–43.
4. ATSDR. Toxicological Profile for Antimony and Compounds. Available: http://www.atsdr.cdc.gov/ToxProfiles/tp23.pdf [accessed 15 May 2016] 1992.
5. Barr, D.B., Wilder, L.C., Caudill, S.P., Gonzalez, A.J., Needham, L.L., Pirkle, J.L., Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113 (2005), 192–200.
6. Bento, D.B., de Souza, B., Steckert, A.V., Dias, R.O., Leffa, D.D., Moreno, S.E., et al. Oxidative stress in mice treated with antileishmanial meglumine antimoniate. Res. Vet. Sci. 95 (2013), 1134–1141.
7. Caldwell, K.L., Jones, R.L., Verdon, C.P., Jarrett, J.M., Caudill, S.P., Osterloh, J.D., Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003–2004. J. Expo. Sci. Environ. Epidemiol. 19 (2009), 59–68.
8. Callahan MA, Slimak MW, Gabel NW, May IP, Fowler CF, Frees JR, et al. Introduction and Technical Background, Metals and Inorganics, Pesticides and PCBs. In: Water-Related Environmental Fate of 129 Priority Pollutants, Vol 1, Chapter 5: Antimony. Office of Water Planning and Standards, Washington, DC, 5-1 to 5-8 1979.
9. Carson, B.L., Ellis, H.V., McCann, J.L., Antimony. Toxicology and Biological Monitoring of Metals in Humans., 21-26, 1986.
10. CDC. National Health and Nutrition Examination Survey: 1999–2000 Data Documentation, Codebook, and Frequencies Available: http://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/LAB06HM.htm [accessed 15 May 2016] 2005.
11. CDC. Continuous NHANES Web Tutorial-Survey Design Factors-Weighting. Available: http://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/Weighting/intro.htm [accessed 15 May 2016] 2013a.
12. CDC. National Biomonitoring Program: Biomonitoring Summary. Available: http://www.cdc.gov/biomonitoring/Antimony_BiomonitoringSummary.html [accessed 15 May 2016] 2013b.
13. CDC. NCHS 2011 Linked Mortality Files Matching Methodology. Available: http://www.cdc.gov/nchs/data/datalinkage/2011_linked_mortality_file_matching_methodology.pdf [accessed 15 May 2016] 2013c.
14. CDC. About the National Health and Nutrition Examination Survey: Introduction. Available: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm [accessed 15 May 2016] 2014.
15. CDC. Analytic Guidelines for NCHS 2011 Linked Mortality Files. Available: http://www.cdc.gov/nchs/data/datalinkage/2011_linked_mortality_analytic_guidelines.pdf [accessed 15 May 2016] 2015a.
16. CDC. Fourth National Report on Human Exposure to Environmental Chemicals. Available: http://www.cdc.gov/biomonitoring/pdf/FourthReport_UpdatedTables_Feb2015.pdf [accessed 15 May 2016] 2015b.
17. CDC. NCHS Surveys 2011 Linked Mortality Files: Public-Use Data Dictionary. Available: http://www.cdc.gov/nchs/data/datalinkage/Public-use_Data_Dictionary.pdf [accessed 15 May 2016] 2015c.
18. Chulay, J.D., Fleckenstein, L., Smith, D.H., Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans. R. Soc. Trop. Med. Hyg. 82 (1988), 69–72.
19. Chulay, J.D., Spencer, H.C., Mugambi, M., Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am.J.Trop. Med. Hyg. 34 (1985), 702–709.
20. Cooper, R.G., Harrison, A.P., The exposure to and health effects of antimony. Indian J. Occup. Environ. Med. 13 (2009), 3–10.
21. Croft, S.L., Seifert, K., Yardley, V., Current scenario of drug development for leishmaniasis. Indian J. Med. Res. 123 (2006), 399–410.
22. De Boeck, M., Kirsch-Volders, M., Lison, D., Cobalt and antimony: genotoxicity and carcinogenicity. Mutat. Res. 533 (2003), 135–152.
23. Felicetti, S.A., Thomas, R.G., McClellan, R.O., Metabolism of two valence states of inhaled antimony in hamsters. Am. Ind. Hyg. Assoc. J. 35 (1974), 292–300.
24. Filella, M., Williams, P.A., Belzile, N., Antimony in the environment: knowns and unknowns. Environ. Chem. 6 (2009), 95–105.
25. Furuta, N., Iijima, A., Kambe, A., Sakai, K., Sato, K., Concentrations, enrichment and predominant sources of Sb and other trace elements in size classified airborne particulate matter collected in Tokyo from 1995 to 2004. J. Environ. Monit. 7 (2005), 1155–1161.
26. Grosskopf, C., Schwerdtle, T., Mullenders, L.H., Hartwig, A., Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets. Chem. Res. Toxicol. 23 (2010), 1175–1183.
27. Hadjikakou, S.K., Ozturk, I.I., Banti, C.N., Kourkoumelis, N., Hadjiliadis, N., Recent advances on antimony (III/V) compounds with potential activity against tumor cells. J. Inorg. Biochem. 153 (2015), 293–305.
28. IARC. Antimony Trioxide and Antimony Trisulfide. Available: http://www.inchem.org/documents/iarc/vol47/47-11.html [accessed 15 May 2016] 1989.
29. Jones, R.D., Survey of antimony workers: mortality 1961–1992. Occup. Environ. Med. 51 (1994), 772–776.
30. Jones, S.R., Atkin, P., Holroyd, C., Lutman, E., Batlle, J.V., Wakeford, R., et al. Lung cancer mortality at a UK tin smelter. Occup. Med. (Lond.) 57 (2007), 238–245.
31. Kentner, M., Leinemann, M., Schaller, K.H., Weltle, D., Lehnert, G., External and internal antimony exposure in starter battery production. Int. Arch. Occup. Environ. Health 67 (1995), 119–123.
32. Kirkland, D., Whitwell, J., Deyo, J., Serex, T., Failure of antimony trioxide to induce micronuclei or chromosomal aberrations in rat bone-marrow after sub-chronic oral dosing. Mutat. Res. 627 (2007), 119–128.
33. Krachler, M., Zheng, J., Koerner, R., Zdanowicz, C., Fisher, D., Shotyk, W., Increasing atmospheric antimony contamination in the northern hemisphere: snow and ice evidence from Devon Island, Arctic Canada. J. Environ. Monit. 7 (2005), 1169–1176.
34. Leonard, A., Gerber, G.B., Mutagenicity, carcinogenicity and teratogenicity of antimony compounds. Mutat. Res. 366 (1996), 1–8.
35. Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.F. 3rd, Feldman, H.I., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150 (2009), 604–612.
36. Li, X., Ge, X., Liang, D., Wei, G., Xu, X., Wang, L., A study on ur-Sb as a biological monitoring index for occupational exposure to antimony trioxide. China Occup. Med. 35 (2008), 67–68.
37. Ludersdorf, R., Fuchs, A., Mayer, P., Skulsuksai, G., Schacke, G., Biological assessment of exposure to antimony and lead in the glass-producing industry. Int. Arch. Occup. Environ. Health 59 (1987), 469–474.
38. Maren, T.H., Otto, G.F., The distribution, excretion, and blood levels of antimony following administration of antimonials to various mammalian species. Fed. Proc., 7, 1948, 243.
39. Menke, A., Muntner, P., Silbergeld, E.K., Platz, E.A., Guallar, E., Cadmium levels in urine and mortality among U.S. adults. Environ. Health Perspect. 117 (2009), 190–196.
40. Navas-Acien, A., Silbergeld, E.K., Sharrett, R., Calderon-Aranda, E., Selvin, E., Guallar, E., Metals in urine and peripheral arterial disease. Environ. Health Perspect. 113 (2005), 164–169.
41. NCHS. Laboratory Procedure Manual, Creatinine. Available: http://www.cdc.gov/NCHS/data/nhanes/nhanes_09_10/BIOPRO_F_met_creatinine.pdf [accessed 15 May 2016] 2011a.
42. NCHS. Laboratory Procedure Manual, Urinary Creatinine. Available: http://www.cdc.gov/NCHS/data/nhanes/nhanes_09_10/ALB_CR_F_met_creatinine.pdf [accessed 15 May 2016] 2011b.
43. NIOSH. Antimony Induction of Heat Shock Proteins in Neonatal Rat Cardiac Myocytes. Available: http://www.cdc.gov/niosh/nioshtic-2/20030659.html [accessed 15 May 2016] 1996.
44. O'Brien, K.M., Upson, K., Cook, N.R., Weinberg, C.R., Environmental chemicals in urine and blood: improving methods for creatinine and lipid adjustment. Environ. Health Perspect. 124 (2016), 220–227.
45. Ortega-Carnicer, J., Alcazar, R., De la Torre, M., Benezet, J., Pentavalent antimonial-induced torsade de pointes. J. Electrocardiol. 30 (1997), 143–145.
46. Otto, G.F., Maren, T.H., Brown, H.W., Blood levels and excretion rates of antimony in persons receiving trivalent and pentavalent antimonials. Am. J. Hyg. 46 (1947), 193–211.
47. Park, S.K., Schwartz, J., Weisskopf, M., Sparrow, D., Vokonas, P.S., Wright, R.O., et al. Low-level lead exposure, metabolic syndrome, and heart rate variability: the VA normative aging study. Environ. Health Perspect. 114 (2006), 1718–1724.
48. Ribeiro, A.L., Drummond, J.B., Volpini, A.C., Andrade, A.C., Passos, V.M., Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine. Braz. J. Med. Biol. Res. 32 (1999), 297–301.
49. Schnorr, T.M., Steenland, K., Thun, M.J., Rinsky, R.A., Mortality in a cohort of antimony smelter workers. Am. J. Ind. Med. 27 (1995), 759–770.
50. Shiue, I., Higher urinary heavy metal, arsenic, and phthalate concentrations in people with high blood pressure: US NHANES, 2009–2010. Blood Press. 23 (2014), 363–369.
51. Shotyk, W., Chen, B., Krachler, M., Lithogenic, oceanic and anthropogenic sources of atmospheric Sb to a maritime blanket bog, Myrarnar, Faroe Islands. J. Environ. Monit. 7 (2005), 1148–1154.
52. Shotyk, W., Krachler, M., Chen, B., Antimony: global environmental contaminant. J. Environ. Monit. 7 (2005), 1135–1136.
53. Sundar, S., Chakravarty, J., Antimony toxicity. Int. J. Environ. Res. Public Health 7 (2010), 4267–4277.
54. Sundar, S., Chakravarty, J., Leishmaniasis: an update of current pharmacotherapy. Expert. Opin. Pharmacother. 14 (2013), 53–63.
55. Tiekink, E.R.T., Antimony and bismuth compounds in oncology. Crit. Rev. Oncol. Hematol. 42 (2002), 217–224.
56. Tirmenstein, M.A., Plews, P.I., Walker, C.V., Woolery, M.D., Wey, H.E., Toraason, M.A., Antimony-induced oxidative stress and toxicity in cultured cardiac myocytes. Toxicol. Appl. Pharmacol. 130 (1995), 41–47.
57. 2 + mobilization during excitation-contraction in cultured cardiac myocytes exposed to antimony. Toxicol. Appl. Pharmacol. 146 (1997), 104–115.
58. Ungureanu, G., Santos, S., Boaventura, R., Botelho, C., Arsenic and antimony in water and wastewater: overview of removal techniques with special reference to latest advances in adsorption. J. Environ. Manag. 151 (2015), 326–342.
59. Wingren, G., Axelson, O., Epidemiologic studies of occupational cancer as related to complex mixtures of trace elements in the art glass industry. Scand. J. Work Environ. Health 19:Suppl. 1 (1993), 95–100.
60. Winship, K.A., Toxicity of antimony and its compounds. Adverse Drug React Acute Poisoning Rev 6 (1987), 67–90.
61. Zeng, D., Zhou, S., Ren, B., Chen, T., Bioaccumulation of antimony and arsenic in vegetables and health risk assessment in the superlarge antimony-mining area, China. J Anal Methods Chem, 2015, 2015, 909724.